8TYO
Structural and biochemical rationale for Beta variant protein booster vaccine broad cross-neutralization of SARS-CoV-2
Summary for 8TYO
Entry DOI | 10.2210/pdb8tyo/pdb |
EMDB information | 41727 |
Descriptor | Spike glycoprotein, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose (3 entities in total) |
Functional Keywords | spike, trimer, surface, viral protein |
Biological source | Severe acute respiratory syndrome coronavirus 2 |
Total number of polymer chains | 3 |
Total formula weight | 418832.42 |
Authors | |
Primary citation | Bruch, E.M.,Zhu, S.,Szymkowicz, L.,Blake, T.,Kiss, T.,James, D.A.,Rak, A.,Narayan, K.,Balmer, M.T.,Chicz, R.M. Structural and biochemical rationale for Beta variant protein booster vaccine broad cross-neutralization of SARS-CoV-2. Sci Rep, 14:2038-2038, 2024 Cited by PubMed: 38263191DOI: 10.1038/s41598-024-52499-1 PDB entries with the same primary citation |
Experimental method | ELECTRON MICROSCOPY (2.75 Å) |
Structure validation
Download full validation report